Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)

NCT06333210 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

421

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

BIOLOGICAL: anti-TRBV9 monoclonal antibody infusions
OTHER: Placebo infusions
DRUG: Adalimumab subcutaneous injection
OTHER: Placebo subcutaneous injection

Sponsor

Biocad